UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MKP1 CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer

Oncogene, 2006-06, Vol.25 (23), p.3335-3345

2006

Volltextzugriff (PDF)

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced metastatic breast cancer

British journal of cancer, 2004-05, Vol.90 (9), p.1740-1746

2004

Volltextzugriff (PDF)

Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2006-10, Vol.58 (4), p.527-531

2006

Volltextzugriff (PDF)

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

British journal of cancer, 2010-05, Vol.102 (10), p.1468-1473

2010

Volltextzugriff (PDF)

Oxycodone: a pharmacological and clinical review

Clinical & translational oncology, 2007-05, Vol.9 (5), p.298-307

2007

Volltextzugriff (PDF)

A critical role for choline kinase-α in the aggressiveness of bladder carcinomas

Oncogene, 2009-07, Vol.28 (26), p.2425-2435

2009

Volltextzugriff (PDF)

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

British journal of cancer, 2006-04, Vol.94 (7), p.969-975

2006

Volltextzugriff (PDF)

Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy

Current cancer drug targets, 2012-02, Vol.12 (2), p.124-131

2012

Volltextzugriff (PDF)

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

Cancer chemotherapy and pharmacology, 2011, Vol.67 (1), p.215-221

2011

Volltextzugriff (PDF)

UFT (tegafur–uracil) in rectal cancer

Annals of oncology, 2008-08, Vol.19 (8), p.1371-1378

2008

Volltextzugriff (PDF)

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy

International journal of colorectal disease, 2009-07, Vol.24 (7), p.741-748

2009

Volltextzugriff (PDF)

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy

Colorectal disease, 2011-09, Vol.13 (9), p.989-998

2011

Volltextzugriff (PDF)

Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group

Cancer, 1996-07, Vol.78 (2), p.211-216

1996

Volltextzugriff (PDF)

Employment in a cohort of breast cancer patients

Occupational medicine (Oxford), 2008-10, Vol.58 (7), p.509-511

2008

Volltextzugriff (PDF)

Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy

Annals of oncology, 2002-05, Vol.13 (5), p.730-736

2002

Volltextzugriff (PDF)

Breast Cancer Prognosis Determined by Gene Expression Profiling: A Quantitative Reverse Transcriptase Polymerase Chain Reaction Study

Journal of clinical oncology, 2005-10, Vol.23 (29), p.7278-7285

2005

Volltextzugriff (PDF)

Phase ii randomised trial of raltitrexed-oxaliplatin vs raltitrexed- irinotecan as first-line treatment in advanced colorectal cancer

British journal of cancer, 2005-11, Vol.93 (11), p.1230-1235

2005

Volltextzugriff (PDF)

Efficacy, tolerability and management of raltitrexed (Tomudex™) monotherapy in patients with advanced colorectal cancer: a review of phase II/III trials

European Journal of Cancer, 2002-03, Vol.38 (4), p.478-486

2002

Volltextzugriff (PDF)

Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study

British journal of cancer, 2005-03, Vol.92 (6), p.1055-1062

2005

Volltextzugriff (PDF)

Descriptive analysis of clinical factors affecting terminally ill cancer patients

Supportive care in cancer, 2009-03, Vol.17 (3), p.261-269

2009

Volltextzugriff (PDF)

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

Chemotherapy (Basel), 2011-01, Vol.57 (2), p.138-144

2011

Volltextzugriff (PDF)

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study

British journal of cancer, 2004-04, Vol.90 (8), p.1502-1507

2004

Volltextzugriff (PDF)

Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer

British journal of cancer, 2004-11, Vol.91 (10), p.1758-1762

2004

Volltextzugriff (PDF)

Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma

Cancer chemotherapy and pharmacology, 2005-02, Vol.55 (2), p.197-202

2005

Volltextzugriff (PDF)

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

Cancer chemotherapy and pharmacology, 2004-12, Vol.54 (6), p.546-552

2004

Volltextzugriff (PDF)

1 – 25 von 403

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(352)
Mit Volltextzugriff
(281)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(203)
Science & Technology
(165)
Life Sciences & Biomedicine
(161)
Male
(140)
Female
(114)
Oncology
(97)
Middle Aged
(96)
Biological And Medical Sciences
(95)
Aged
(85)
Adult
(84)
Medical Sciences
(76)
Animals
(69)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(44)
Chemotherapy
(41)
Pharmacology. Drug Treatments
(39)
Antineoplastic Agents
(34)
Cats
(33)
Aged, 80 And Over
(32)
Tumors
(31)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MKP1 CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer

Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced metastatic breast cancer

Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer

Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer

Oxycodone: a pharmacological and clinical review

A critical role for choline kinase-α in the aggressiveness of bladder carcinomas

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

Analysis of the concordance in the EGFR pathway status between primary tumors and related metastases of colorectal cancer patients:implications for cancer therapy

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

UFT (tegafur–uracil) in rectal cancer

Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy

Immunohistochemical analysis of tumour regression grade for rectal cancer after neoadjuvant chemoradiotherapy

Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin: A phase II study of the ONCOPAZ Cooperative Group

Employment in a cohort of breast cancer patients

Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy

Breast Cancer Prognosis Determined by Gene Expression Profiling: A Quantitative Reverse Transcriptase Polymerase Chain Reaction Study

Phase ii randomised trial of raltitrexed-oxaliplatin vs raltitrexed- irinotecan as first-line treatment in advanced colorectal cancer

Efficacy, tolerability and management of raltitrexed (Tomudex™) monotherapy in patients with advanced colorectal cancer: a review of phase II/III trials

Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study

Descriptive analysis of clinical factors affecting terminally ill cancer patients

Irinotecan-Cetuximab-Bevacizumab as a Salvage Treatment in Heavily Pretreated Metastatic Colorectal Cancer Patients: A Retrospective Observational Study

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study

Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer

Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

Suchergebnisse filtern